John Bennett, a partner in Goodwin’s IP Litigation group, represents leading companies in high-stakes disputes involving intellectual property and complex technology. Mr. Bennett has over 15 years of experience trying cases on behalf of clients like Teva Pharmaceuticals, Fresenius Kabi and Actavis Pharmaceuticals. He has developed expertise representing both plaintiffs and defendants in pharmaceutical patent disputes brought under the Hatch-Waxman Act. Mr. Bennett’s engagements have included trial representation before various federal courts and the Patent Trial and Appeal Board, appellate representation before the Federal Circuit and other courts of appeal and work on numerous patent and trade secret cases involving a variety of technologies including medical devices, telecommunications and internet content delivery systems.

Mr. Bennett also performs pro bono work and his engagements have included federal litigation which led to the parole of a Mariel Cuban refugee client detained by the federal government for over 14 years.

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Bennett’s recent representations include:

  • Trial and appellate counsel for Teva Pharmaceuticals in patent litigation concerning its blockbuster innovative treatment for multiple sclerosis, Copaxone®. After two bench trials, Teva prevailed on all nine patents asserted and the Federal Circuit affirmed the judgment as to four of the asserted patents. The case was subsequently appealed to the U.S. Supreme Court, resulting in a landmark victory for Teva on the standard of review in claim construction in Teva v. Sandoz.
  • Trial counsel for Actavis Pharmaceuticals as generic defendant in patent litigation concerning the ulcerative colitis drug UCERIS®. The U.S. District Court, District of Delaware ruled at trial that Actavis’ product did not infringe the asserted patents.
  • Lead counsel for Fresenius Kabi as generic defendant in patent litigation concerning the oncology drug KYPROLIS® (carfilzomib) pending before the U.S. District Court, District of Delaware.
  • Lead counsel for Fresenius Kabi, Gland Pharma Ltd. and USV North America as generic defendants in patent litigation concerning the bone disorder treatment Zometa® brought in the U.S. District Court, District of New Jersey.  Favorable settlements were obtained.
  • Trial counsel for Teva Pharmaceuticals in patent litigation concerning its branded treatment for Parkinson’s disease, Azilect®. After a bench trial, the U.S. District Court, District of New Jersey found Teva’s patent valid and infringed.
  • Lead counsel for Fresenius Kabi in Patent Trial and Appeal Board inter-partes review proceeding concerning patent covering Fresenius’s branded parenteral anesthetic, Diprivan®.  
  • Trial counsel for Fresenius Kabi as generic defendant in patent litigation concerning the intravenous acetaminophen product OFIRMEV®. The case settled favorably.
  • Trial and appellate counsel for Teva Pharmaceuticals as a generic defendant in patent litigation concerning Sanofi-Aventis’s blockbuster treatment for deep vein thrombosis, Lovenox®. After a bench trial, the U.S. District Court, Central District of California ruled that the asserted patent was unenforceable due to inequitable conduct. This ruling was affirmed by the Federal Circuit.
Professional Activities

Mr. Bennett is a member of the Boston and Massachusetts Bar Associations.

Professional Experience

Prior to joining Goodwin, Mr. Bennett was an associate with Palmer & Dodge in Boston, where his practice focused on intellectual property matters.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2000
Boston College Law School
B.A., 1996
Dartmouth College

(cum laude with high honors)

Admissions

Bar

Massachusetts

Courts

U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the Fifth Circuit
U.S. Court of Appeals for the Tenth Circuit
U.S. District Court for the District of Massachusetts
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师